— Know what they know.
Not Investment Advice

Financial News

Sentiment 46.2 5329 articles 2917 bullish 1267 bearish Full Index →
Accenture Stock Hits 52-Week Low - Here's Why

Accenture Stock Hits 52-Week Low - Here's Why

Accenture plc (NYSE:ACN) shares fell Thursday after the company's fiscal second-quarter 2026 results, as a cautious outlook overshadowed an...
Johnson & Johnson-Protagonist Therapeutics Partnered New Pso

Johnson & Johnson-Protagonist Therapeutics Partnered New Psoriasis Pill Wins FDA Nod, Shakes Up Competition With AbbVie

On Wednesday, the U.S. Food and Drug Administration (FDA) approved Icotyde (icotrokinra), an interleukin-23 (IL-23) receptor antagonist for...
Johnson & Johnson-Protagonist Therapeutics Partnered New Pso

Johnson & Johnson-Protagonist Therapeutics Partnered New Psoriasis Pill Wins FDA Nod, Shakes Up Competition With AbbVie

On Wednesday, the U.S. Food and Drug Administration (FDA) approved Icotyde (icotrokinra), an interleukin-23 (IL-23) receptor antagonist for...
Alibaba Posts Downbeat Earnings, Joins Guardian Pharmacy, Mi

Alibaba Posts Downbeat Earnings, Joins Guardian Pharmacy, Micron And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

U.S. stock futures were slightly lower this morning, with the S&P 5000 futures falling around 0.1% on Thursday. Shares of Alibaba Group Holding...
Alibaba Posts Downbeat Earnings, Joins Guardian Pharmacy, Mi

Alibaba Posts Downbeat Earnings, Joins Guardian Pharmacy, Micron And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

U.S. stock futures were slightly lower this morning, with the S&P 5000 futures falling around 0.1% on Thursday. Shares of Alibaba Group Holding...
📰

Halper Sadeh LLC is Investigating Whether RLYB, TALK, UNF are Obtaining Fair Deals for their Shareholders

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...
📰

Halper Sadeh LLC is Investigating Whether KW, ACLX are Obtaining Fair Deals for their Shareholders

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...
📰

Halper Sadeh LLC is Investigating Whether RLYB, TALK, UNF are Obtaining Fair Deals for their Shareholders

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...
📰

Securities Litigation on Behalf of Purchasers of Biogen, Inc. Securities (BIIB) Certified as Class Action

BOSTON, March 19, 2026 (GLOBE NEWSWIRE) -- Block & Leviton LLP announces that the United States District Court for the District of...
📰

DarioHealth Corp. (DRIO) Reports Q4 Loss, Beats Revenue Estimates

DarioHealth (DRIO) delivered earnings and revenue surprises of +48.88% and +2.17%, respectively, for the quarter ended December 2025. Do the numbers...
📰

DarioHealth Corp. (DRIO) Reports Q4 Loss, Beats Revenue Estimates

DarioHealth (DRIO) delivered earnings and revenue surprises of +48.88% and +2.17%, respectively, for the quarter ended December 2025. Do the numbers...
📰

Pelthos Therapeutics Inc. (PTHS) Reports Q4 Loss, Tops Revenue Estimates

Pelthos Therapeutics Inc. (PTHS) delivered earnings and revenue surprises of +28.35% and +3.78%, respectively, for the quarter ended December 2025....
📰

Pelthos Therapeutics Inc. (PTHS) Reports Q4 Loss, Tops Revenue Estimates

Pelthos Therapeutics Inc. (PTHS) delivered earnings and revenue surprises of +28.35% and +3.78%, respectively, for the quarter ended December 2025....
China's E-Commerce Wars Are Crushing Alibaba's Profits

China's E-Commerce Wars Are Crushing Alibaba's Profits

Alibaba Group Holding Ltd. (NYSE:BABA) shares tanked on Thursday following its fiscal third-quarter results, as the e-commerce giant...
Earnings Scheduled For March 19, 2026

Earnings Scheduled For March 19, 2026

Companies Reporting Before The Bell • Neuraxis (AMEX:NRXS) is projected to report quarterly loss at $0.21 per share on revenue of $850 thousand. •...
Earnings Scheduled For March 19, 2026

Earnings Scheduled For March 19, 2026

Companies Reporting Before The Bell • Neuraxis (AMEX:NRXS) is projected to report quarterly loss at $0.21 per share on revenue of $850 thousand. •...
Earnings Scheduled For March 19, 2026

Earnings Scheduled For March 19, 2026

Companies Reporting Before The Bell • Neuraxis (AMEX:NRXS) is projected to report quarterly loss at $0.21 per share on revenue of $850 thousand. •...
Earnings Scheduled For March 19, 2026

Earnings Scheduled For March 19, 2026

Companies Reporting Before The Bell • Neuraxis (AMEX:NRXS) is projected to report quarterly loss at $0.21 per share on revenue of $850 thousand. •...
Earnings Scheduled For March 19, 2026

Earnings Scheduled For March 19, 2026

Companies Reporting Before The Bell • Neuraxis (AMEX:NRXS) is projected to report quarterly loss at $0.21 per share on revenue of $850 thousand. •...
Earnings Scheduled For March 19, 2026

Earnings Scheduled For March 19, 2026

Companies Reporting Before The Bell • Neuraxis (AMEX:NRXS) is projected to report quarterly loss at $0.21 per share on revenue of $850 thousand. •...
Earnings Scheduled For March 19, 2026

Earnings Scheduled For March 19, 2026

Companies Reporting Before The Bell • Neuraxis (AMEX:NRXS) is projected to report quarterly loss at $0.21 per share on revenue of $850 thousand. •...
Earnings Scheduled For March 19, 2026

Earnings Scheduled For March 19, 2026

Companies Reporting Before The Bell • Neuraxis (AMEX:NRXS) is projected to report quarterly loss at $0.21 per share on revenue of $850 thousand. •...
Earnings Scheduled For March 19, 2026

Earnings Scheduled For March 19, 2026

Companies Reporting Before The Bell • Neuraxis (AMEX:NRXS) is projected to report quarterly loss at $0.21 per share on revenue of $850 thousand. •...
Earnings Scheduled For March 19, 2026

Earnings Scheduled For March 19, 2026

Companies Reporting Before The Bell • Neuraxis (AMEX:NRXS) is projected to report quarterly loss at $0.21 per share on revenue of $850 thousand. •...
Earnings Scheduled For March 19, 2026

Earnings Scheduled For March 19, 2026

Companies Reporting Before The Bell • Neuraxis (AMEX:NRXS) is projected to report quarterly loss at $0.21 per share on revenue of $850 thousand. •...
Earnings Scheduled For March 19, 2026

Earnings Scheduled For March 19, 2026

Companies Reporting Before The Bell • Neuraxis (AMEX:NRXS) is projected to report quarterly loss at $0.21 per share on revenue of $850 thousand. •...
Earnings Scheduled For March 19, 2026

Earnings Scheduled For March 19, 2026

Companies Reporting Before The Bell • Neuraxis (AMEX:NRXS) is projected to report quarterly loss at $0.21 per share on revenue of $850 thousand. •...
Earnings Scheduled For March 19, 2026

Earnings Scheduled For March 19, 2026

Companies Reporting Before The Bell • Neuraxis (AMEX:NRXS) is projected to report quarterly loss at $0.21 per share on revenue of $850 thousand. •...
Earnings Scheduled For March 19, 2026

Earnings Scheduled For March 19, 2026

Companies Reporting Before The Bell • Neuraxis (AMEX:NRXS) is projected to report quarterly loss at $0.21 per share on revenue of $850 thousand. •...
Earnings Scheduled For March 19, 2026

Earnings Scheduled For March 19, 2026

Companies Reporting Before The Bell • Neuraxis (AMEX:NRXS) is projected to report quarterly loss at $0.21 per share on revenue of $850 thousand. •...
Earnings Scheduled For March 19, 2026

Earnings Scheduled For March 19, 2026

Companies Reporting Before The Bell • Neuraxis (AMEX:NRXS) is projected to report quarterly loss at $0.21 per share on revenue of $850 thousand. •...
📰

NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results

Conference call will be held today, Thursday, March 19 at 9:00 am ET Conference call will be held today, Thursday, March 19 at 9:00 am ET
Armata Pharmaceuticals Delays Announcement of Fourth Quarter

Armata Pharmaceuticals Delays Announcement of Fourth Quarter and Full-Year 2025 Results and Provides Corporate Update

LOS ANGELES, March 19, 2026 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage...
📰
DarioHealth Reports Fourth Quarter and Full Year 2025 Financ

DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

Fourth quarter 2025 revenues grew sequentially to $5.2 million as compared to $5.0 million in the third quarter of 2025 2025 full-year revenue...
T-Mobile, Verizon, AT&T Go All-In On Discounts As Churn Surg

T-Mobile, Verizon, AT&T Go All-In On Discounts As Churn Surge Hits

Promotional activity among the "Big 3" U.S. carriers—AT&T Inc. (NYSE:T), Verizon Communications Inc. (NYSE:VZ) and T-Mobile US, Inc....
How Apple Is Winning China's Brutal Smartphone Price War

How Apple Is Winning China's Brutal Smartphone Price War

China's smartphone sales fell 4% year over year in the first nine weeks of 2026, according to Counterpoint Research's China Weekly...
Centaurus Financial Inc. Lowers Holdings in UnitedHealth Gro

Centaurus Financial Inc. Lowers Holdings in UnitedHealth Group Incorporated $UNH

Centaurus Financial Inc. cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 52.6% in the third quarter,...
Centaurus Financial Inc. Lowers Holdings in UnitedHealth Gro

Centaurus Financial Inc. Lowers Holdings in UnitedHealth Group Incorporated $UNH

Centaurus Financial Inc. cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 52.6% in the third quarter,...
Centaurus Financial Inc. Lowers Holdings in UnitedHealth Gro

Centaurus Financial Inc. Lowers Holdings in UnitedHealth Group Incorporated $UNH

Centaurus Financial Inc. cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 52.6% in the third quarter,...
SoftBank Project Fee Slashed By Over 90% Amid Uncertainty Ov

SoftBank Project Fee Slashed By Over 90% Amid Uncertainty Over $550 Billion US-Japan Trade Deal: Report

The anticipated ¥1 trillion ($6.3 billion) fee for SoftBank Group Corp. (OTC:SFTBY) from a U.S.-Japan project has been slashed by over 90% due to...
📰

EUDA Announces Reverse Stock Split of its Ordinary Shares

SINGAPORE, March 19, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore based...
Stock Market Today: S&P 500, Dow Jones Futures Decline As Tr

Stock Market Today: S&P 500, Dow Jones Futures Decline As Trump Warns Iran Against Qatar Strikes—Micron, FedEx, Constellation Energy In Focus

U.S. stock futures fell on Thursday following Wednesday’s declines. Futures of the major benchmark indices were lower. Markets processed the...
Boston Scientific Corporation $BSX Shares Sold by AIA Group

Boston Scientific Corporation $BSX Shares Sold by AIA Group Ltd

AIA Group Ltd cut its position in Boston Scientific Corporation (NYSE:BSX – Free Report) by 7.7% in the third quarter, according to its most...
Boston Scientific Corporation $BSX Shares Sold by AIA Group

Boston Scientific Corporation $BSX Shares Sold by AIA Group Ltd

AIA Group Ltd cut its position in Boston Scientific Corporation (NYSE:BSX – Free Report) by 7.7% in the third quarter, according to its most...
« Prev 1 20 21 22 23 Next »

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms